Consequently, Grb2 is recruited into the Plexin B1 receptor complex and interacts with p190 RhoGAP via its SH3 domain, which mediates RhoA deactivation and subsequently inhibits the motility of breast carcinoma cells. This evidence concerns the gene GRB2 and breast carcinoma.